AMRN
Price
$16.00
Change
+$0.55 (+3.56%)
Updated
Sep 26 closing price
Capitalization
330.92M
NVO
Price
$55.61
Change
-$0.43 (-0.77%)
Updated
Sep 26 closing price
Capitalization
241.93B
38 days until earnings call
Interact to see
Advertisement

AMRN vs NVO

Header iconAMRN vs NVO Comparison
Open Charts AMRN vs NVOBanner chart's image
Amarin
Price$16.00
Change+$0.55 (+3.56%)
Volume$69.55K
Capitalization330.92M
Novo-Nordisk A/S
Price$55.61
Change-$0.43 (-0.77%)
Volume$17.74M
Capitalization241.93B
AMRN vs NVO Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. NVO commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Buy and NVO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (AMRN: $16.00 vs. NVO: $55.61)
Brand notoriety: AMRN: Notable vs. NVO: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMRN: 114% vs. NVO: 87%
Market capitalization -- AMRN: $330.92M vs. NVO: $241.93B
AMRN [@Pharmaceuticals: Major] is valued at $330.92M. NVO’s [@Pharmaceuticals: Major] market capitalization is $241.93B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • NVO’s FA Score: 2 green, 3 red.
According to our system of comparison, NVO is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while NVO’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 5 bearish.
  • NVO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AMRN and NVO are a bad buy in the short-term.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +4.23% price change this week, while NVO (@Pharmaceuticals: Major) price change was -9.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Reported Earning Dates

NVO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($242B) has a higher market cap than AMRN($331M). AMRN YTD gains are higher at: 64.948 vs. NVO (-33.570). NVO has higher annual earnings (EBITDA): 154B vs. AMRN (-70.12M). NVO has more cash in the bank: 18.9B vs. AMRN (299M). AMRN has less debt than NVO: AMRN (7.34M) vs NVO (99.3B). NVO has higher revenues than AMRN: NVO (312B) vs AMRN (219M).
AMRNNVOAMRN / NVO
Capitalization331M242B0%
EBITDA-70.12M154B-0%
Gain YTD64.948-33.570-193%
P/E RatioN/A14.17-
Revenue219M312B0%
Total Cash299M18.9B2%
Total Debt7.34M99.3B0%
FUNDAMENTALS RATINGS
AMRN vs NVO: Fundamental Ratings
AMRN
NVO
OUTLOOK RATING
1..100
1777
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9615
PRICE GROWTH RATING
1..100
4286
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVO's Valuation (16) in the Pharmaceuticals Major industry is significantly better than the same rating for AMRN (90) in the Pharmaceuticals Other industry. This means that NVO’s stock grew significantly faster than AMRN’s over the last 12 months.

NVO's Profit vs Risk Rating (79) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that NVO’s stock grew similarly to AMRN’s over the last 12 months.

NVO's SMR Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for AMRN (96) in the Pharmaceuticals Other industry. This means that NVO’s stock grew significantly faster than AMRN’s over the last 12 months.

AMRN's Price Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for NVO (86) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew somewhat faster than NVO’s over the last 12 months.

NVO's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that NVO’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNNVO
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 3 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
40%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPL0.71N/A
+0.03%
Solitario Resources Corp
VRNA106.69N/A
N/A
Verona Pharma plc
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
LAW6.46-0.02
-0.31%
CS Disco
TNK52.37-0.21
-0.40%
Teekay Tankers Ltd

AMRN and

Correlation & Price change

A.I.dvisor tells us that AMRN and OGN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRN and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+3.56%
OGN - AMRN
28%
Poorly correlated
+0.89%
PFE - AMRN
25%
Poorly correlated
+0.68%
SNY - AMRN
23%
Poorly correlated
+1.04%
BIIB - AMRN
22%
Poorly correlated
+1.25%
NVO - AMRN
22%
Poorly correlated
-0.77%
More

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with ADAP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-0.77%
ADAP - NVO
38%
Loosely correlated
+15.75%
MRK - NVO
35%
Loosely correlated
+1.24%
GMAB - NVO
35%
Loosely correlated
+0.80%
TECH - NVO
35%
Loosely correlated
+2.71%
BCAB - NVO
35%
Loosely correlated
+6.22%
More